Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb;74(1):26-32.
doi: 10.1007/s00393-014-1446-4.

[Regulatory T cells and rheumatic diseases]

[Article in German]
Affiliations
Review

[Regulatory T cells and rheumatic diseases]

[Article in German]
J Y Humrich et al. Z Rheumatol. 2015 Feb.

Abstract

Background: Regulatory T cells (Treg) are crucial for the maintenance of immunological peripheral tolerance by controlling the activation and expansion of autoreactive cells; therefore, they make a decisive contribution to the prevention and control of autoimmune diseases.

Objectives: The aims of this article are to summarize the history and role of Treg in science and medicine, to provide a brief introduction to the development and function, to explain how failures in Treg biology contribute to the development of autoimmune disease, to explain their specific role in particular rheumatic diseases and to provide an introduction to the therapeutic use of Treg in autoimmune diseases.

Methods: Relevant original literature and review articles were analyzed and the results are summarized in this article.

Results: Disorders in Treg biology can contribute to the development of rheumatic diseases in various ways. In addition, their capability to suppress autoimmunity renders Treg an attractive target for the treatment of rheumatic diseases.

Conclusions: The concept of Treg-mediated immunoregulation has evolved into an independent field of research in immunology and medicine. First translational approaches and clinical studies confirmed the therapeutic efficacy of Treg in the treatment of autoimmune syndromes.

PubMed Disclaimer

References

    1. Immunology. 1970 May;18(5):723-37 - PubMed
    1. Nat Rev Immunol. 2009 Feb;9(2):83-9 - PubMed
    1. Ann Rheum Dis. 2013 Apr;72(4):473-5 - PubMed
    1. Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):204-9 - PubMed
    1. Curr Rheumatol Rep. 2013 Sep;15(9):352 - PubMed

MeSH terms

LinkOut - more resources